Search PubMed⌕ Search

Biomedical subjects

D R Jobes

Publications and source records attributed to D R Jobes.

At least 19 recordsLinked to original sources
PubMed1995

Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.

Individual aspects of heparin or protamine dosing have been better controlled than previously as useful tests have become available. Although many variables including drug potency, drug source, and individual patient response have been separately identified, there has not been an attempt to integrate them into a single management strategy. This study was undertaken to learn whether more precise control of drug variables and patient response would affect blood loss and transfusion requirements. Adult patients having primary cardiac operations were prospectively randomized into two groups. A control group received heparin and protamine by conventional methods. The test group received heparin and protamine according to in vitro predictive tests integrating drugs, tests, and patient response. Supplemental protamine was given in this group only if heparin was specifically found by testing. Anticoagulation in all patients was maintained at an activated coagulation time greater than 400 seconds, and any other treatment for bleeding was at the discretion of the clinical team caring for the patients. Testing and treatment for both groups followed routine practice after patient arrival in the intensive care unit. Test patients received slightly more heparin and a markedly lower dose of protamine than the control patients. Testing identified patients with decreased heparin sensitivity (preoperative heparin therapy) and correctly predicted the effective heparin dose. Supplemental protamine was given twice as often to control patients and frequently when no heparin was detectable (retrospectively). Test patients exhibited less 24-hour chest tube drainage (671 ml versus 1298 ml) and fewer patients received transfusion (9/22 versus 18/24) with fewer donor exposures (22/22 versus 101/24). The management strategy used for heparin and protamine added accuracy and precision, which was associated with improved hemostasis. Although the observation is valid, the mechanism or mechanisms are not completely clear. Nevertheless, it is reasonable to apply basic pharmacologic principles and establishment of consistent, predictable protocols that are beneficial. It is against this background that the efficacy of additional drugs or equipment should be assessed. It is quite possible that only marginal if any improvement in hemostasis may be found in patients having primary, uncomplicated cardiac operation with the addition of more costly drugs or equipment.

Aged↗
PubMed1994

The metabolic effects of surface cooling neonates prior to cardiac surgery.

Neonates undergoing cardiac surgery at The Children's Hospital of Philadelphia frequently developed metabolic acidemia as they passively cooled prior to the start of cardiopulmonary bypass. This study was performed in an attempt to identify the mechanism for this acidemia. After receiving an initial dose of fentanyl (10 micrograms/kg) and pancuronium, 22 neonates were randomly assigned to maintain normothermia by active warming (Group I), or to permit passive cooling (Group II) before surgery. Arterial blood samples were obtained prior to, and at 10 and 45 min after entering the operating room for the analysis of pH, gas tensions, lactate, pyruvate, plasma free fatty acids, acetoacetate, beta-hydroxybutyrate, total CO2, and glucose concentrations. In the last 11 patients studied, the observation period was extended to 75 min at which time another arterial blood sample was obtained. There was a steady decrease in heart rate as the Group II patients cooled; however, arterial blood pressure did not change in either group. There were no changes in blood values measured in Group I neonates. In the Group II patients, there was a progressive decline in calculated base excess, total CO2, and an increase in serum lactate as the patients cooled. The metabolic acidemia that develops in neonates represents lactate accumulation as a consequence of surface cooling prior to surgery and the institution of cardiopulmonary bypass. Whether lactate accumulates as a result of anaerobic metabolism in underperfused tissue beds or reduced hepatic clearance could not be distinguished in this study. Since neither clinically significant hemodynamic changes nor differences in outcome were found between the two groups, the authors believe this mild lactic acidemia is inconsequential and does not require therapy.

Acidosis↗
PubMed1993

Desmopressin does not decrease bleeding after cardiac operation in young children.

Young children undergoing complex cardiac operation lose more blood after cardiopulmonary bypass than do older patients. This study was designed to investigate the effect of desmopressin on blood loss during the first 24 hours after cardiac operation in children undergoing principally complex surgical procedures. The study consisted of a randomized, blinded comparison of 112 pediatric patients who received either desmopressin 0.3 microgram/kg or saline solution placebo after cardiopulmonary bypass. A coagulation profile including bleeding time, quantitation of von Willebrand factor, and qualitative analysis of the factor VII:von Willebrand factor complex was performed before, 30 minutes after, and 3 hours after the operation. Blood loss and blood replacement were recorded for the first 24 hours after the operation. The surgeon classified the technical difficulty of each procedure as simple or complex. Statistical analysis was performed with Student's unpaired t test and chi 2 analysis. Significance was defined as p < 0.05. Results are listed as mean +/- standard deviation. Data collection was completed for 95 patients. The mean age of all patients was 26 +/- 40 months, and the mean weight was 10 +/- 11 kg, with 84% undergoing complex procedures. There were no differences between the desmopressin and placebo groups with respect to age, weight, or surgical complexity. Twenty-four-hour blood loss and replacement between the desmopressin and placebo groups were not different (blood loss: desmopressin 30 +/- 33 ml/kg, placebo 35 +/- 36; blood replacement: desmopressin 65 +/- 43 ml/kg, placebo 64 +/- 46 ml/kg). Coagulation profiles between the desmopressin and placebo groups were not different at any time. We conclude that desmopressin does not reduce blood loss or blood replacement in young children after cardiopulmonary bypass for either simple or complex cardiac surgical procedures.

Adolescent↗
PubMed1992

Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome.

Circulatory and metabolic homeostasis in patients with hypoplastic left heart syndrome is dependent on a delicate balance between systemic and pulmonary blood flow. Hypocarbia can result in a marked decrease in pulmonary vascular resistance accompanied by pulmonary overcirculation, systemic hypotension, metabolic acidosis, and death. This report illustrates that early and precise control of the arterial carbon dioxide tension using inspired carbon dioxide can be effective in preventing or treating instability arising during management of a patient with hypoplastic left heart syndrome.

Acidosis, Respiratory↗
PubMed1992

The effect of administering or withholding dextrose in pre-bypass intravenous fluids on intraoperative blood glucose concentrations in infants undergoing hypothermic circulatory arrest.

Thirty-six fasted infants under 1 year of age who were scheduled for elective cardiac surgery using hypothermic bypass with circulatory arrest were randomized to receive a lactated Ringer's (LR) solution (group I) or a LR with 5% dextrose solution (group II) in the pre-bypass period. Marked increases in blood glucose concentrations were found following institution of bypass and circulatory arrest in the children in both groups. There was no correlation between the amount of dextrose infused in the pre-bypass period and the presence of hyperglycemia following institution of bypass. A single patient in group I was hypoglycemic (blood glucose less than 30 mg/dL) on the initial glucose determination and the blood glucose did not increase during the pre-bypass period. Elimination of dextrose from the parenteral fluids given before bypass will not eliminate hyperglycemia following institution of bypass; however, it may expose pediatric patients to the risks of hypoglycemia before bypass.

Blood Glucose↗
PubMed1989

Evaluation of a user-operated patient-side blood gas and chemistry monitor in children undergoing cardiac surgery.

A study was performed to evaluate a user-operated patient-side blood gas and chemistry monitor (GEM-STAT, Mallinckrodt Sensor Systems, Ann Arbor, MI) for the first time in a group of infants and children with congenital heart disease undergoing cardiac surgery. Paired blood samples from 18 patients were analyzed by the test instrument and by standard clinical laboratory instruments. One failure of the test instrument, malfunction of a cartridge, occurred during the evaluation. The integrated and external quality control functions gave readings within the manufacturer's tolerance. The differences between the measurements obtained using the GEM-STAT and the standard laboratory instruments for five of the six variables are summarized as follows (mean +/- SD, units of measure, number of samples): pH (-0.017 +/- 0.02, 132), PaCO2 (-1.90 +/- 3.3 mm Hg, 130), hematocrit (-1.3 +/- 2.3%, 129), potassium (-0.17 +/- 0.20 mmol, 112) and sodium (-2.0 +/- 3.3 mmol, 112). The mean difference in the measurements of PaO2 in the clinically important range defined by the upper quality control limit for oxygen tension of 172 mm Hg for the GEM-STAT is: (-0.20 +/- 7.26 mm Hg, 51). The mean difference between the measurements for PaO2s below the lowest quality control point (60 mm Hg) was (-2.3 +/- 5.5 mm Hg, 30). The values for all variables obtained from the GEM-STAT during the trial period, with the exception of the PaO2 less than 60 mm Hg, showed good correlation with the laboratory over the clinically useful range.(ABSTRACT TRUNCATED AT 250 WORDS)

Blood Chemical Analysis↗
PubMed1989

Comparison of oral and intramuscular preanesthetic medication for pediatric inpatient surgery.

The child's fear of injections coupled with the concern that the psychologic advantage of intramuscular premedication may be all or in part negated by the trauma of injections prompted the authors to seek an oral preanesthetic medication to safely and reliably replace injections. The authors describe the results of a prospective, randomized, double-blind study comparing the pharmacologic effects of oral versus injectable preanesthetic medication in 67 healthy pediatric inpatients older than 1 yr. Children given the oral medication (meperidine 3.0 mg/kg, pentobarbital 4.0 mg/kg) were significantly more drowsy in the holding area (P less than 0.001) and more cooperative at the time of induction of anesthesia (P less than 0.01) than the children given intramuscular medication (morphine 0.1 mg/kg, pentobarbital 4.0 mg/kg). There were no other differences between the two groups. These data demonstrate that oral preanesthetic medication can be as or more effective compared with intramuscular medication in producing the desired effects without adverse side effects. As a result of this study, the benefits of preanesthetic medication can now be achieved in nearly all surgical patients without injections.

Administration, Oral↗